Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Restructuring Costs (2023)

Updated

Dianthus Therapeutics (DNTH) reported Restructuring Costs of $1.92 million for Q2 2023, down 89.3% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Restructuring Costs (2023) Analysis & Trends

Over the twelve months ended Jun 30, 2023, Dianthus Therapeutics' Restructuring Costs came in at $19.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.92 Mn
Mar 31, 2023 18.00 Mn
API Access

Dianthus Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=DNTH&period=max&api_key=YOUR_API_KEY